Fig. 2
From: AKT2 drives cancer progression and is negatively modulated by miR-124 in human lung adenocarcinoma
Up-regulated AKT2 expression is associated with poor prognosis in LUAD patients. a and b Kaplan-Meier plots from Kaplan-Meier plotter shows the correlation between AKT2 expression and overall survival (a) or progression-free survival in patients with NSCLC (b). c-f Kaplan-Meier plotter data set shows the correlation between AKT2 expression and the overall survival or progression-free survival in LUAD (c, d) and LUSC (e, f) patients. g and h Public data from TIMER database shows the correlation between AKT2 expression and overall survival in LUAD (g) and LUSC (h) patients. OS, overall survival; PFS, progression-free survival. *P < 0.05; **P < 0.01; ***P < 0.001